WEN Acquisition Corp. 10-Q Summary
Business Context and Reporting Period
Company: WEN Acquisition Corp (WENNU/WENN/WENNW)
Reporting Period: Quarter ended June 30, 2025 (Inception: January 13, 2025)
Status: Cayman Islands exempted company; Special Purpose Acquisition Company (SPAC).
Operations: No operating revenues. Activities limited to formation, IPO execution, and identifying a target for a Business Combination.
Deadline: Must consummate a Business Combination by May 19, 2027, or risk liquidation.
Key Financial Metrics
| Metric | Value (as of June 30, 2025) |
|---|---|
| Trust Account Balance | $301,553,603 (Includes ~$1.4M interest) |
| Cash (Outside Trust) | $921,309 |
| Working Capital | $994,155 |
| Net Income (3 Months) | $1,174,630 |
| Net Income (Inception to Date) | $1,130,686 |
| Operating Expenses (3 Months) | $228,973 |
| Deferred Underwriting Fee | $14,289,750 |
| Shares Outstanding (Class A) | 30,015,000 (Subject to redemption) |
| Shares Outstanding (Class B) | 7,503,750 (Founder Shares) |
Material Changes and IPO Details
The Company consummated its Initial Public Offering (IPO) on May 19, 2025, shortly before the end of the reporting period. This represents the primary material change from the prior period (inception).
- IPO Proceeds: Sold 30,015,000 Units at $10.00 per unit, generating gross proceeds of $300,150,000. This included the full exercise of the underwriters' over-allotment option (3,915,000 units).
- Private Placement: Simultaneously sold 7,220,000 Private Placement Warrants to the Sponsor and Cantor Fitzgerald for $7,220,000.
- Trust Funding: $300,150,000 was deposited into the Trust Account immediately following the IPO.
- Transaction Costs: Total transaction costs were $20,196,742, comprising a $5,220,000 cash underwriting fee, $14,289,750 deferred fee, and $686,992 in other offering costs.
Outlook, Risks, and Management Commentary
Liquidity: Management believes current cash ($921,309) and working capital are sufficient to fund operations for at least one year. The Sponsor has provided an unsecured promissory note (repaid) and may provide "Working Capital Loans" up to $1,500,000 if needed, which may be convertible into warrants.
Business Combination: The Company has not selected a target. It must complete a merger with a target having a fair market value of at least 80% of the Trust Account balance (excluding deferred fees and taxes) by May 19, 2027.
Risks:
- Delisting Risk: If the Company fails to meet the Nasdaq 36-Month Requirement (completion by May 15, 2028), securities may be suspended and delisted.
- Redemption Risk: Public shareholders may redeem shares for their pro-rata share of the Trust Account (approx. $10.05 per share as of June 30, 2025), potentially reducing funds available for a transaction.
- Market Conditions: Geopolitical instability, inflation, and market downturns could hinder the ability to find a target.
Investor Verification Checklist
- Trust Account Yield: Verify the current interest rate on U.S. Treasury securities held in the Trust Account to assess the growth of the redemption value.
- Deferred Fee Terms: Confirm the conditions under which the $14.3M deferred underwriting fee is payable (only upon successful Business Combination).
- Extension Provisions: Review the Amended and Restated Articles for the specific mechanics and shareholder approval thresholds required to extend the May 19, 2027 deadline.
- Sponsor Commitment: Assess the financial capacity of the Sponsor (Wen Sponsor LLC) to fulfill indemnification obligations if third-party claims reduce Trust Account funds below $10.00 per share.
- Warrant Exercise Price: Note the $11.50 exercise price for Public and Private Warrants and the $18.00 threshold for potential warrant redemption by the Company.